Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Sponsor
La Jolla Pharmaceutical Company (Industry)
Overall Status
Completed
CT.gov ID
NCT00035308
Collaborator
(none)
330
82
4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether LJP 394 (abetimus sodium) is safe and effective in delaying and reducing renal flares in patients with lupus nephritis.

Condition or Disease Intervention/Treatment Phase
  • Drug: Abetimus sodium (LJP 394)
Phase 3

Detailed Description

LJP 394 (abetimus sodium) is a unique drug that is specifically designed to lower production of antibodies to double-stranded DNA. These antibodies are believed to contribute to kidney damage in patients with Systemic Lupus Erythematosus (SLE). Rising levels of these antibodies seem to be associated with exacerbations of kidney disease that are known as "renal flares." Currently, anti-inflammatory and cytotoxic drugs are used to treat renal flares. Unfortunately, these drugs are often associated with certain unpleasant side effects. The purpose of this trial is to determine whether LJP 394 can delay or reduce the number of renal flares. It is possible that if renal flares can be delayed or reduced, patients may be able to take smaller amounts of anti-inflammatory or cytotoxic drugs and therefore suffer fewer of the side effects associated with these treatments.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Safety and Efficacy Trial of LJP 394 in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease
Study Completion Date :
Dec 1, 2002

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria

    • Diagnosed with SLE

    • Historical evidence of SLE renal disease

    • Elevated levels of dsDNA antibodies

    • Weight of 40 kg or greater

    Exclusion Criteria

    • Active SLE renal disease

    • Use of certain anti-inflammatory or cytotoxic therapies or therapeutic interventions during the months immediately before dosing

    • Clinical laboratory test values outside of certain limits

    • Malignant disease or immunodeficiency syndrome

    • Acute or chronic infections

    • History of serious heart disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Birmingham Alabama United States 35294
    2 Rheumatology Associates of North Alabama Huntsville Alabama United States 35801
    3 Montgomery Rheumatology Associates Montgomery Alabama United States 36111
    4 Arizona Arthritis & Rheumatology Paradise Valley Arizona United States 85253
    5 Allergy and Rheumatology Medical Clinic La Jolla California United States 92037
    6 Davida-USC Dialysis Center Los Angeles California United States 90033
    7 Wallace Rheumatic Study Center Los Angeles California United States 90048
    8 Private Practice Los Angeles California United States 90057
    9 UCLA School of Medicine Los Angeles California United States 90095
    10 Boling Clinical Trials Rancho Cucamonga California United States 91730
    11 Investigative Clinical Research Rancho Cucamonga California United States 91730
    12 Private Practice San Mateo California United States 94401
    13 Harbor-UCLA Research & Education Institute, Medicine/Rheumatology Division Torrance California United States 90502
    14 University of Connecticut Health Center, Division of Rheumatology Farmington Connecticut United States 06030-1310
    15 Arthritis and Osteoporosis Center, PC Hamden Connecticut United States 06518
    16 CRIA Research Ft. Lauderdale Florida United States 33334
    17 nTouch Research Corp. St. Petersburg Florida United States 33707
    18 Emory University School of Medicine, Renal Division Atlanta Georgia United States 30322
    19 Private Practice Macon Georgia United States 31211
    20 Intermountain Research Center Boise Idaho United States 83702
    21 Radiant Research-Boise Boise Idaho United States 83704
    22 Northwestern University Chicago Illinois United States 60611
    23 Rheumatology Associates Chicago Illinois United States 60612
    24 University of Chicago Chicago Illinois United States 60637
    25 Rheumatology Consultants Evansville Indiana United States 47714
    26 Rheumatology Associates, PC Indianapolis Indiana United States 46260
    27 University of Louisville, Dept of Medicine/Division of Rheumatology Louisville Kentucky United States 40292
    28 LSU Health Sciences Center, Department of Rheumatology New Orleans Louisiana United States 70112-2822
    29 Ochsner Clinic New Orleans Louisiana United States 70121
    30 Johns Hopkins University Baltimore Maryland United States 21205
    31 SOMARC, Trials, LLC Greenbelt Maryland United States 20770
    32 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
    33 University of Michigan Health System, Internal Medicine-Rheumatology Ann Arbor Michigan United States 48109-0358
    34 Wayne State University, Rheumatology Division Detroit Michigan United States 48201
    35 Saint Louis University Health Sciences Center St. Louis Missouri United States 63104
    36 Washington University, Renal Division St. Louis Missouri United States 63110
    37 HIS Clinical Trials Jersey City New Jersey United States 07306
    38 SUNY-Downstate Brooklyn New York United States 11203
    39 Nephrology Associates, PC Flushing New York United States 11355
    40 NSUH-Division of Rheumatology Manhasset New York United States 11030
    41 Ambulatory Clinical Research Center, Hospital for Joint Diseases Orthopaedic Institute, NYU New York New York United States 10003
    42 Hospital for Joint Diseases, Department of Rheumatology New York New York United States 10003
    43 Hospital for Joint Diseases, NYU Medical Center New York New York United States 10003
    44 Mt. Sinai Medical Center New York New York United States 10029
    45 Columbia-Presbyterian Medical Center New York New York United States 10032
    46 AAIR Research Center Rochester New York United States 14618
    47 Wake Forest University School of Medicine Winston Salem North Carolina United States 27157
    48 Metrohealth Medical Center, Division of Rheumatology Cleveland Ohio United States 44109
    49 Oklahoma Medical Research Foundation Oklahoma City Oklahoma United States 73104
    50 Oklahoma State University Tulsa Oklahoma United States 74114
    51 Healthcare Research Consultants Tulsa Oklahoma United States 74135
    52 Altoona Center for Clinical Research Duncansville Pennsylvania United States 16635
    53 Thomas Jefferson University, Division of Rheumatology Philadelphia Pennsylvania United States 19107
    54 University of Pittsburgh, Div. of Rheumatology and Clinical Immun. Pittsburgh Pennsylvania United States 15261
    55 Medical University of South Carolina Charleston South Carolina United States 29425
    56 Dakota Regional Rheumatology Rapid City South Dakota United States 57701
    57 Medical Specialty Clinic Jackson Tennessee United States 38301
    58 University of Tennessee, Memphis Memphis Tennessee United States 38163
    59 Presbyterian Hospital of Dallas, Arthritis Consultation Center Dallas Texas United States 75231-4496
    60 Radiant Research - Dallas Dallas Texas United States 75235
    61 Texas Tech University Health Sciences Center, Department of Internal Medicine Lubbock Texas United States 79430
    62 San Antonio Kidney Disease Center, Research Center San Antonio Texas United States 78229
    63 Clinical Research and Consulting Center Fairfax Virginia United States 22031
    64 MedSource, Inc. Richmond Virginia United States 23229
    65 Arthritis Northwest Spokane Washington United States 99204
    66 Medical College of Wisconsin Milwaukee Wisconsin United States 53226
    67 Division of Rheumatology, Department of Internal Medicine Vienna Austria A-1090
    68 Arthritis Center of Excellence, Toronto Western Hospital, University Health Network Toronto Ontario Canada M5T-2S8
    69 Hospital Maisonnueve-Rosemont Montreal Quebec Canada H1T 4B3
    70 Service De Rhumatologie Hopital de Hautepierre Strasbourg Cedex France 67098
    71 Universitatklinikum Charite, Medizinische Universitatsklinik Berlin Germany 10117
    72 MNR-Klinik/heinrich-Heine-University Dusseldorf Dusseldorf Germany 40225
    73 Department for Internal Medicine and Institute of Immunology and Rheumatology Erlangen Germany D-91054
    74 U.O di Reumatologia, Dipartimento di Medicina Interna, Universita di Pisa Pisa Italy 56126
    75 Insituto Nacional de Ciencias Medicas Y Nutricion Salvador Zubiran, Depto. de Immunology y Rheumatology Mexico City Mexico 14000
    76 Hospital General Valle de Hebron Servicio Medicina Interna. Edificio Barcelona Spain 08035
    77 Hospital Clinic y Provinical de Barcelona, Unitat de Malalties Autoimmunes Barcelona Spain 08036
    78 Hospital Universitario La Paz Servico de Medicina Madrid Spain 28046
    79 Department of Rheumatology, University Hospital of Lund Lund Sweden S-22185
    80 Department of Rheumatology, Karolinska Hospital Stockholm Sweden S-17176
    81 Rheumatology and Rehabilitation Unit Leeds United Kingdom LS2 3EX
    82 Lupus Research Unit St. Thomas Hospital, The Rayne Institute London United Kingdom SE1 7EH

    Sponsors and Collaborators

    • La Jolla Pharmaceutical Company

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00035308
    Other Study ID Numbers:
    • LJP 394-90-09
    First Posted:
    May 3, 2002
    Last Update Posted:
    Sep 25, 2006
    Last Verified:
    Dec 1, 2002

    Study Results

    No Results Posted as of Sep 25, 2006